ID   FYB1_HUMAN              Reviewed;         783 AA.
AC   O15117; A8K2Y8; B4DLN2; E9PBV9; O00359; Q9NZI9;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 2.
DT   28-JUN-2023, entry version 205.
DE   RecName: Full=FYN-binding protein 1 {ECO:0000312|HGNC:HGNC:4036};
DE   AltName: Full=Adhesion and degranulation promoting adaptor protein;
DE            Short=ADAP;
DE   AltName: Full=FYB-120/130;
DE            Short=p120/p130;
DE   AltName: Full=FYN-T-binding protein;
DE   AltName: Full=SLAP-130;
DE   AltName: Full=SLP-76-associated phosphoprotein;
GN   Name=FYB1 {ECO:0000312|HGNC:HGNC:4036}; Synonyms=FYB, SLAP130;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FYB-120), INTERACTION WITH FYN AND
RP   LCP2, AND VARIANT PHE-672.
RC   TISSUE=Tonsil;
RX   PubMed=9207119; DOI=10.1073/pnas.94.14.7493;
RA   da Silva A.J., Li Z., de Vera C., Canto E., Findell P., Rudd C.E.;
RT   "Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-
RT   containing leukocyte protein 76 and modulates interleukin 2 production.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7493-7498(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FYB-120), PROTEIN SEQUENCE OF 363-370,
RP   AND VARIANT PHE-672.
RX   PubMed=9115214; DOI=10.1074/jbc.272.18.11674;
RA   Musci M.A., Hendricks-Taylor L.R., Motto D.G., Paskind M., Kamens J.,
RA   Turck C.W., Koretzky G.A.;
RT   "Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T
RT   cell antigen receptor-stimulated protein tyrosine kinases.";
RL   J. Biol. Chem. 272:11674-11677(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FYB-130), FUNCTION, INTERACTION WITH
RP   EVL, AND VARIANT PHE-672.
RX   PubMed=10747096; DOI=10.1083/jcb.149.1.181;
RA   Krause M., Sechi A.S., Konradt M., Monner D., Gertler F.B., Wehland J.;
RT   "Fyn-binding protein (Fyb)/SLP-76-associated protein (SLAP),
RT   Ena/vasodilator-stimulated phosphoprotein (VASP) proteins and the Arp2/3
RT   complex link T cell receptor (TCR) signaling to the actin cytoskeleton.";
RL   J. Cell Biol. 149:181-194(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS FYB-130 AND 3), AND
RP   VARIANT PHE-672.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM FYB-130), AND VARIANT
RP   PHE-672.
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH SKAP1 AND SKAP2.
RX   PubMed=9755858; DOI=10.1016/s0014-5793(98)01040-0;
RA   Marie-Cardine A., Verhagen A.M., Eckerskorn C., Schraven B.;
RT   "SKAP-HOM, a novel adaptor protein homologous to the FYN-associated protein
RT   SKAP55.";
RL   FEBS Lett. 435:55-60(1998).
RN   [9]
RP   INTERACTION WITH SKAP1.
RX   PubMed=9748251; DOI=10.1074/jbc.273.40.25789;
RA   Marie-Cardine A., Hendricks-Taylor L.R., Boerth N.J., Zhao H., Schraven B.,
RA   Koretzky G.A.;
RT   "Molecular interaction between the Fyn-associated protein SKAP55 and the
RT   SLP-76-associated phosphoprotein SLAP-130.";
RL   J. Biol. Chem. 273:25789-25795(1998).
RN   [10]
RP   INTERACTION WITH SKAP1 AND SKAP2, AND SUBCELLULAR LOCATION.
RX   PubMed=9671755; DOI=10.1073/pnas.95.15.8779;
RA   Liu J., Kang H., Raab M., da Silva A.J., Kraeft S.-K., Rudd C.E.;
RT   "FYB (FYN binding protein) serves as a binding partner for lymphoid protein
RT   and FYN kinase substrate SKAP55 and a SKAP55-related protein in T cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:8779-8784(1998).
RN   [11]
RP   INTERACTION WITH SKAP2.
RX   PubMed=10942756; DOI=10.1074/jbc.m001439200;
RA   Asazuma N., Wilde J.I., Berlanga O., Leduc M., Leo A., Schweighoffer E.,
RA   Tybulewicz V., Bon C., Liu S.K., McGlade C.J., Schraven B., Watson S.P.;
RT   "Interaction of linker for activation of T cells with multiple adapter
RT   proteins in platelets activated by the glycoprotein VI-selective ligand,
RT   convulxin.";
RL   J. Biol. Chem. 275:33427-33434(2000).
RN   [12]
RP   INTERACTION WITH SKAP1.
RX   PubMed=10856234; DOI=10.1093/emboj/19.12.2889;
RA   Kang H., Freund C., Duke-Cohan J.S., Musacchio A., Wagner G., Rudd C.E.;
RT   "SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY
RT   motif in immune cell adaptor SKAP55.";
RL   EMBO J. 19:2889-2899(2000).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [14]
RP   INTERACTION WITH SKAP1 AND FYN, AND FUNCTION.
RX   PubMed=15849195; DOI=10.1074/jbc.m413201200;
RA   Huang Y., Norton D.D., Precht P., Martindale J.L., Burkhardt J.K.,
RA   Wange R.L.;
RT   "Deficiency of ADAP/Fyb/SLAP-130 destabilizes SKAP55 in Jurkat T cells.";
RL   J. Biol. Chem. 280:23576-23583(2005).
RN   [15]
RP   INTERACTION WITH SKAP1.
RX   PubMed=16461356; DOI=10.1074/jbc.m508774200;
RA   Duke-Cohan J.S., Kang H., Liu H., Rudd C.E.;
RT   "Regulation and function of SKAP-55 non-canonical motif binding to the SH3c
RT   domain of adhesion and degranulation-promoting adaptor protein.";
RL   J. Biol. Chem. 281:13743-13750(2006).
RN   [16]
RP   FUNCTION.
RX   PubMed=16980616; DOI=10.1128/mcb.00331-06;
RA   Kliche S., Breitling D., Togni M., Pusch R., Heuer K., Wang X., Freund C.,
RA   Kasirer-Friede A., Menasche G., Koretzky G.A., Schraven B.;
RT   "The ADAP/SKAP55 signaling module regulates T-cell receptor-mediated
RT   integrin activation through plasma membrane targeting of Rap1.";
RL   Mol. Cell. Biol. 26:7130-7144(2006).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [18]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46; SER-457; TYR-571; SER-573
RP   AND TYR-651, VARIANT [LARGE SCALE ANALYSIS] PHE-672, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46; SER-225; SER-329 AND
RP   SER-457, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   INVOLVEMENT IN THC3.
RX   PubMed=25516138; DOI=10.1186/s12881-014-0135-0;
RA   Hamamy H., Makrythanasis P., Al-Allawi N., Muhsin A.A., Antonarakis S.E.;
RT   "Recessive thrombocytopenia likely due to a homozygous pathogenic variant
RT   in the FYB gene: case report.";
RL   BMC Med. Genet. 15:135-135(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   INVOLVEMENT IN THC3, AND VARIANT THC3 131-TRP--ASP-783 DEL.
RX   PubMed=25876182; DOI=10.1111/jth.12966;
RA   Levin C., Koren A., Pretorius E., Rosenberg N., Shenkman B., Hauschner H.,
RA   Zalman L., Khayat M., Salama I., Elpeleg O., Shalev S.;
RT   "Deleterious mutation in the FYB gene is associated with congenital
RT   autosomal recessive small-platelet thrombocytopenia.";
RL   J. Thromb. Haemost. 13:1285-1292(2015).
RN   [25]
RP   INTERACTION WITH LCP2; SKAP1; FYN AND LCK.
RX   PubMed=27335501; DOI=10.4049/jimmunol.1501913;
RA   Jung S.H., Yoo E.H., Yu M.J., Song H.M., Kang H.Y., Cho J.Y., Lee J.R.;
RT   "ARAP, a novel adaptor protein, is required for TCR signaling and integrin-
RT   mediated adhesion.";
RL   J. Immunol. 197:942-952(2016).
RN   [26]
RP   STRUCTURE BY NMR OF 683-771.
RX   PubMed=15062083; DOI=10.1016/j.str.2004.02.021;
RA   Heuer K., Kofler M., Langdon G., Thiemke K., Freund C.;
RT   "Structure of a helically extended SH3 domain of the T cell adapter protein
RT   ADAP.";
RL   Structure 12:603-610(2004).
CC   -!- FUNCTION: Acts as an adapter protein of the FYN and LCP2 signaling
CC       cascades in T-cells (By similarity). May play a role in linking T-cell
CC       signaling to remodeling of the actin cytoskeleton (PubMed:10747096,
CC       PubMed:16980616). Modulates the expression of IL2 (By similarity).
CC       Involved in platelet activation (By similarity). Prevents the
CC       degradation of SKAP1 and SKAP2 (PubMed:15849195). May be involved in
CC       high affinity immunoglobulin epsilon receptor signaling in mast cells
CC       (By similarity). {ECO:0000250|UniProtKB:D3ZIE4,
CC       ECO:0000250|UniProtKB:O35601, ECO:0000269|PubMed:10747096,
CC       ECO:0000269|PubMed:15849195, ECO:0000269|PubMed:16980616}.
CC   -!- SUBUNIT: Part of a complex consisting of SKAP2, FYB1 and PTPNS1 (By
CC       similarity). Part of a complex consisting of SKAP2, FYB1 and LILRB3 (By
CC       similarity). Part of a complex consisting of SKAP1, FYB1 and CLNK (By
CC       similarity). Interacts with CLNK (via its SH2 domain); this interaction
CC       allows SKAP1 and FYB1 to recruit FYN to the complex, thus promoting the
CC       phosphorylation of CLNK by FYN (By similarity). Interacts with FYN
CC       (PubMed:9207119, PubMed:15849195, PubMed:27335501). Interacts with LCP2
CC       (PubMed:9207119, PubMed:27335501). Interacts with SKAP1
CC       (PubMed:9755858, PubMed:9748251, PubMed:9671755, PubMed:10856234,
CC       PubMed:15849195, PubMed:16461356, PubMed:27335501). Interacts with
CC       SKAP2 (PubMed:9755858, PubMed:9671755, PubMed:10942756). Interacts with
CC       FASLG (PubMed:19807924). Interacts with EVL (PubMed:10747096).
CC       Interacts with TMEM47 (By similarity). Interacts with LCK
CC       (PubMed:27335501). {ECO:0000250|UniProtKB:D3ZIE4,
CC       ECO:0000250|UniProtKB:O35601, ECO:0000269|PubMed:10747096,
CC       ECO:0000269|PubMed:10856234, ECO:0000269|PubMed:10942756,
CC       ECO:0000269|PubMed:15849195, ECO:0000269|PubMed:16461356,
CC       ECO:0000269|PubMed:19807924, ECO:0000269|PubMed:27335501,
CC       ECO:0000269|PubMed:9207119, ECO:0000269|PubMed:9671755,
CC       ECO:0000269|PubMed:9748251, ECO:0000269|PubMed:9755858}.
CC   -!- INTERACTION:
CC       O15117; P06241: FYN; NbExp=4; IntAct=EBI-1753267, EBI-515315;
CC       O15117; Q13094: LCP2; NbExp=9; IntAct=EBI-1753267, EBI-346946;
CC       O15117; P16333: NCK1; NbExp=3; IntAct=EBI-1753267, EBI-389883;
CC       O15117; O43639: NCK2; NbExp=3; IntAct=EBI-1753267, EBI-713635;
CC       O15117; Q86WV1: SKAP1; NbExp=6; IntAct=EBI-1753267, EBI-2477305;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9671755}. Nucleus
CC       {ECO:0000255|PROSITE-ProRule:PRU00768}. Cell junction
CC       {ECO:0000250|UniProtKB:O35601}. Note=Colocalizes with TMEM47 at cell-
CC       cell contacts in podocytes. {ECO:0000250|UniProtKB:O35601}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=FYB-120;
CC         IsoId=O15117-1; Sequence=Displayed;
CC       Name=FYB-130;
CC         IsoId=O15117-2; Sequence=VSP_042309;
CC       Name=3;
CC         IsoId=O15117-3; Sequence=VSP_047288, VSP_042309;
CC   -!- TISSUE SPECIFICITY: Expressed in hematopoietic tissues such as myeloid
CC       and T-cells, spleen and thymus. Not expressed in B-cells, nor in non-
CC       lymphoid tissues.
CC   -!- PTM: T-cell receptor ligation leads to increased tyrosine
CC       phosphorylation.
CC   -!- DISEASE: Thrombocytopenia 3 (THC3) [MIM:273900]: A form of
CC       thrombocytopenia, a hematologic disorder defined by a decrease in the
CC       number of platelets in circulating blood, resulting in the potential
CC       for increased bleeding and decreased ability for clotting. THC3 is an
CC       autosomal recessive form characterized by onset in infancy.
CC       {ECO:0000269|PubMed:25516138, ECO:0000269|PubMed:25876182}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF001862; AAB62226.1; -; mRNA.
DR   EMBL; U93049; AAC51300.1; -; mRNA.
DR   EMBL; AF198052; AAF62400.1; -; mRNA.
DR   EMBL; AK290403; BAF83092.1; -; mRNA.
DR   EMBL; AK297077; BAG59594.1; -; mRNA.
DR   EMBL; AC008964; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010633; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025471; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471119; EAW55984.1; -; Genomic_DNA.
DR   EMBL; BC117449; AAI17450.1; -; mRNA.
DR   EMBL; BC143645; AAI43646.1; -; mRNA.
DR   CCDS; CCDS47200.1; -. [O15117-1]
DR   CCDS; CCDS54848.1; -. [O15117-2]
DR   CCDS; CCDS58945.1; -. [O15117-3]
DR   RefSeq; NP_001230022.1; NM_001243093.1. [O15117-3]
DR   RefSeq; NP_001456.3; NM_001465.4. [O15117-2]
DR   RefSeq; NP_955367.1; NM_199335.3. [O15117-1]
DR   RefSeq; XP_006714527.1; XM_006714464.2. [O15117-2]
DR   RefSeq; XP_006714528.1; XM_006714465.2.
DR   RefSeq; XP_006714529.1; XM_006714466.2.
DR   RefSeq; XP_011512310.1; XM_011514008.2. [O15117-3]
DR   RefSeq; XP_011512311.1; XM_011514009.1. [O15117-2]
DR   RefSeq; XP_011512312.1; XM_011514010.1. [O15117-2]
DR   PDB; 1RI9; NMR; -; A=683-771.
DR   PDB; 2GTJ; NMR; -; A=486-579.
DR   PDB; 2GTO; NMR; -; A=486-579.
DR   PDBsum; 1RI9; -.
DR   PDBsum; 2GTJ; -.
DR   PDBsum; 2GTO; -.
DR   AlphaFoldDB; O15117; -.
DR   BMRB; O15117; -.
DR   SMR; O15117; -.
DR   BioGRID; 108809; 19.
DR   CORUM; O15117; -.
DR   DIP; DIP-42204N; -.
DR   ELM; O15117; -.
DR   IntAct; O15117; 27.
DR   MINT; O15117; -.
DR   STRING; 9606.ENSP00000427114; -.
DR   GlyCosmos; O15117; 3 sites, 1 glycan.
DR   GlyGen; O15117; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; O15117; -.
DR   PhosphoSitePlus; O15117; -.
DR   BioMuta; FYB1; -.
DR   OGP; O15117; -.
DR   jPOST; O15117; -.
DR   MassIVE; O15117; -.
DR   MaxQB; O15117; -.
DR   PeptideAtlas; O15117; -.
DR   ProteomicsDB; 4545; -.
DR   ProteomicsDB; 48451; -. [O15117-1]
DR   ProteomicsDB; 48452; -. [O15117-2]
DR   Antibodypedia; 23110; 381 antibodies from 38 providers.
DR   DNASU; 2533; -.
DR   Ensembl; ENST00000351578.12; ENSP00000316460.7; ENSG00000082074.19. [O15117-1]
DR   Ensembl; ENST00000512982.4; ENSP00000425845.3; ENSG00000082074.19. [O15117-2]
DR   Ensembl; ENST00000515010.5; ENSP00000426346.1; ENSG00000082074.19. [O15117-1]
DR   Ensembl; ENST00000646045.2; ENSP00000493623.1; ENSG00000082074.19. [O15117-3]
DR   GeneID; 2533; -.
DR   KEGG; hsa:2533; -.
DR   MANE-Select; ENST00000512982.4; ENSP00000425845.3; NM_001465.6; NP_001456.3. [O15117-2]
DR   UCSC; uc003jls.4; human. [O15117-1]
DR   AGR; HGNC:4036; -.
DR   CTD; 2533; -.
DR   DisGeNET; 2533; -.
DR   GeneCards; FYB1; -.
DR   HGNC; HGNC:4036; FYB1.
DR   HPA; ENSG00000082074; Group enriched (bone marrow, lymphoid tissue).
DR   MalaCards; FYB1; -.
DR   MIM; 273900; phenotype.
DR   MIM; 602731; gene.
DR   neXtProt; NX_O15117; -.
DR   OpenTargets; ENSG00000082074; -.
DR   Orphanet; 566192; Congenital autosomal recessive small-platelet thrombocytopenia.
DR   PharmGKB; PA28452; -.
DR   VEuPathDB; HostDB:ENSG00000082074; -.
DR   eggNOG; ENOG502QTTQ; Eukaryota.
DR   GeneTree; ENSGT00530000063460; -.
DR   HOGENOM; CLU_339375_0_0_1; -.
DR   InParanoid; O15117; -.
DR   OMA; KSSTWSW; -.
DR   OrthoDB; 5403214at2759; -.
DR   PhylomeDB; O15117; -.
DR   TreeFam; TF337003; -.
DR   PathwayCommons; O15117; -.
DR   Reactome; R-HSA-202433; Generation of second messenger molecules.
DR   Reactome; R-HSA-391160; Signal regulatory protein family interactions.
DR   SignaLink; O15117; -.
DR   SIGNOR; O15117; -.
DR   BioGRID-ORCS; 2533; 4 hits in 1152 CRISPR screens.
DR   ChiTaRS; FYB; human.
DR   EvolutionaryTrace; O15117; -.
DR   GeneWiki; FYB; -.
DR   GenomeRNAi; 2533; -.
DR   Pharos; O15117; Tbio.
DR   PRO; PR:O15117; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; O15117; protein.
DR   Bgee; ENSG00000082074; Expressed in monocyte and 180 other tissues.
DR   ExpressionAtlas; O15117; baseline and differential.
DR   Genevisible; O15117; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0008289; F:lipid binding; IEA:InterPro.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0005102; F:signaling receptor binding; TAS:UniProtKB.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IBA:GO_Central.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IBA:GO_Central.
DR   CDD; cd11867; hSH3_ADAP; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 2.
DR   InterPro; IPR043443; FYB1/2-like.
DR   InterPro; IPR035540; FYB_hSH3.
DR   InterPro; IPR029294; hSH3.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR16830:SF13; FYN-BINDING PROTEIN 1; 1.
DR   PANTHER; PTHR16830; SH2 CONTAINING ADAPTOR PRAM-1 RELATED; 1.
DR   Pfam; PF14603; hSH3; 1.
DR   Pfam; PF07653; SH3_2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SH3-domain; 2.
DR   PROSITE; PS50002; SH3; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell junction;
KW   Coiled coil; Cytoplasm; Direct protein sequencing; Disease variant;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; SH3 domain.
FT   CHAIN           1..783
FT                   /note="FYN-binding protein 1"
FT                   /id="PRO_0000087396"
FT   DOMAIN          511..572
FT                   /note="SH3 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          700..768
FT                   /note="SH3 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          1..502
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          348..448
FT                   /note="Interaction with SKAP1"
FT   REGION          598..678
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          456..507
FT                   /evidence="ECO:0000255"
FT   MOTIF           462..465
FT                   /note="SH2-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           469..505
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           595..598
FT                   /note="SH2-binding; to LCP2"
FT   MOTIF           625..628
FT                   /note="SH2-binding; to FYN"
FT   MOTIF           674..700
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1..49
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        237..251
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        276..292
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        348..364
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        368..389
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        390..427
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        462..502
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         3
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35601"
FT   MOD_RES         46
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163"
FT   MOD_RES         225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         457
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         571
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         573
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         580
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35601"
FT   MOD_RES         651
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   VAR_SEQ         1
FT                   /note="M -> MDGKADVKSLM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047288"
FT   VAR_SEQ         636
FT                   /note="G -> GSTLQVQEKSNTWSWGILKMLKGKDDRKKSIREKPKVSDSDNNEGSS
FT                   (in isoform FYB-130 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10747096,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042309"
FT   VARIANT         51
FT                   /note="P -> L (in dbSNP:rs1642515)"
FT                   /id="VAR_056880"
FT   VARIANT         131..783
FT                   /note="Missing (in THC3)"
FT                   /evidence="ECO:0000269|PubMed:25876182"
FT                   /id="VAR_078810"
FT   VARIANT         332
FT                   /note="K -> R (in dbSNP:rs3749741)"
FT                   /id="VAR_056881"
FT   VARIANT         672
FT                   /note="V -> F (in dbSNP:rs379707)"
FT                   /evidence="ECO:0000269|PubMed:10747096,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9115214, ECO:0000269|PubMed:9207119,
FT                   ECO:0007744|PubMed:19690332"
FT                   /id="VAR_060592"
FT   CONFLICT        27
FT                   /note="N -> S (in Ref. 4; BAF83092)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        273
FT                   /note="P -> L (in Ref. 2; AAC51300)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        275
FT                   /note="L -> V (in Ref. 1; AAB62226)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        541
FT                   /note="R -> C (in Ref. 4; BAF83092)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        674
FT                   /note="K -> E (in Ref. 4; BAF83092)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        729
FT                   /note="V -> A (in Ref. 4; BAF83092)"
FT                   /evidence="ECO:0000305"
FT   HELIX           498..504
FT                   /evidence="ECO:0007829|PDB:2GTJ"
FT   STRAND          514..520
FT                   /evidence="ECO:0007829|PDB:2GTJ"
FT   STRAND          526..528
FT                   /evidence="ECO:0007829|PDB:2GTO"
FT   STRAND          537..541
FT                   /evidence="ECO:0007829|PDB:2GTJ"
FT   STRAND          546..548
FT                   /evidence="ECO:0007829|PDB:2GTJ"
FT   STRAND          551..553
FT                   /evidence="ECO:0007829|PDB:2GTJ"
FT   STRAND          559..562
FT                   /evidence="ECO:0007829|PDB:2GTO"
FT   HELIX           564..566
FT                   /evidence="ECO:0007829|PDB:2GTJ"
FT   STRAND          567..569
FT                   /evidence="ECO:0007829|PDB:2GTJ"
FT   HELIX           572..575
FT                   /evidence="ECO:0007829|PDB:2GTO"
FT   HELIX           690..698
FT                   /evidence="ECO:0007829|PDB:1RI9"
FT   STRAND          736..750
FT                   /evidence="ECO:0007829|PDB:1RI9"
FT   TURN            751..753
FT                   /evidence="ECO:0007829|PDB:1RI9"
FT   STRAND          754..759
FT                   /evidence="ECO:0007829|PDB:1RI9"
FT   HELIX           760..762
FT                   /evidence="ECO:0007829|PDB:1RI9"
SQ   SEQUENCE   783 AA;  85387 MW;  4EE28EF12AA0E457 CRC64;
     MAKYNTGGNP TEDVSVNSRP FRVTGPNSSS GIQARKNLFN NQGNASPPAG PSNVPKFGSP
     KPPVAVKPSS EEKPDKEPKP PFLKPTGAGQ RFGTPASLTT RDPEAKVGFL KPVGPKPINL
     PKEDSKPTFP WPPGNKPSLH SVNQDHDLKP LGPKSGPTPP TSENEQKQAF PKLTGVKGKF
     MSASQDLEPK PLFPKPAFGQ KPPLSTENSH EDESPMKNVS SSKGSPAPLG VRSKSGPLKP
     AREDSENKDH AGEISSLPFP GVVLKPAASR GGPGLSKNGE EKKEDRKIDA AKNTFQSKIN
     QEELASGTPP ARFPKAPSKL TVGGPWGQSQ EKEKGDKNSA TPKQKPLPPL FTLGPPPPKP
     NRPPNVDLTK FHKTSSGNST SKGQTSYSTT SLPPPPPSHP ASQPPLPASH PSQPPVPSLP
     PRNIKPPFDL KSPVNEDNQD GVTHSDGAGN LDEEQDSEGE TYEDIEASKE REKKREKEEK
     KRLELEKKEQ KEKEKKEQEI KKKFKLTGPI QVIHLAKACC DVKGGKNELS FKQGEQIEII
     RITDNPEGKW LGRTARGSYG YIKTTAVEID YDSLKLKKDS LGAPSRPIED DQEVYDDVAE
     QDDISSHSQS GSGGIFPPPP DDDIYDGIEE EDADDGFPAP PKQLDMGDEV YDDVDTSDFP
     VSSAEMSQGT NVGKAKTEEK DLKKLKKQEK EEKDFRKKFK YDGEIRVLYS TKVTTSITSK
     KWGTRDLQVK PGESLEVIQT TDDTKVLCRN EEGKYGYVLR SYLADNDGEI YDDIADGCIY
     DND
//
